China-based Wiskind Cleanroom has secured a contract for the design and construction of a new animal vaccine production base in Brazil.
The project marks a strategic partnership with a prominent Brazilian biopharmaceutical company.
The win also represents a significant milestone for Wiskind in the South American biomedical sector.
The new facility will comprise six separate buildings, including a virus diagnosis building, a virus workshop, a bacteria workshop, an animal house, a bacteria diagnosis building, and a research and development centre.
Key operational zones will comply with ABSL-3 standards, meeting biosafety requirements set by the World Health Organization
The total construction area exceeds 12,000 sqm.
Once completed, the project will become Brazil’s first high-level veterinary Good Manufacturing Practice (GMP) benchmark facility, integrating virus diagnosis, vaccine production, and R&D testing.
The facility is expected to set a new standard for veterinary vaccine production in the region.
A notable feature of the project is the implementation of an Animal Biosafety Level 3 (ABSL-3) protection system, incorporating a negative pressure gradient control system across all areas.
Once completed, the project will become Brazil’s first high-level veterinary Good Manufacturing Practice benchmark facility
Key operational zones will comply with ABSL-3 standards, meeting biosafety requirements set by the World Health Organization (WHO), the European Union (EU), and Brazil's Ministry of Agriculture, Livestock and Food Supply (MAPA).
The construction phase will involve the parallel development of all six individual buildings, facilitated by the use of Building Information Modelling (BIM) technology to enable multi-disciplinary, collaborative construction management.
This approach is anticipated to reduce the traditional construction timeline by over 30%, setting a new benchmark for similar projects in the sector.
Wiskind Cleanroom, headquartered in Shandong, China, specialises in the design, manufacture, and installation of modular cleanroom systems for biopharmaceutical, healthcare, and high-tech industries.
The company provides integrated cleanroom engineering solutions globally, with a focus on innovative technologies and international quality standards.
Top image: Representatives sign the agreement
